Evidence map›Paper›PMID 39807108›Full record

ArticleOncology letters2025

Type III pleuropulmonary blastoma: A case report.

Shuai Luo, Xiaoxue Tian, Ting Xu, Jinjing Wang

Abstract readCase Reports
In one paragraph

Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shuai LuoDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.
Xiaoxue TianDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.
Ting XuDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.
Jinjing WangDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pleuropulmonary blastoma (PPB) is an uncommon malignant neoplasm occurring in infants. The disease is intimately linked to mutations in the Dcr-1 homolog and ribonuclease type III (DICER1) genes. Imaging techniques are crucial for diagnosing PPB, yet distinguishing PPB from other pulmonary masses proves challenging. Early detection of PPB is problematic, and it is often diagnosed at an advanced pathological stage with a poor prognosis. The present report discusses a PPB case and evaluates its clinical manifestations, imaging characteristics, pathological features and molecular genetic changes. The patient was a 3-year-old female who presented to Affiliated Hospital of Zunyi Medical University (Zunyi, China) with an unexplained cough. Chest computed tomography revealed a mass in the right thoracic cavity, which was identified as a neoplastic lesion and considered a potential PPB. Surgical intervention was performed. The postoperative pathological examination confirmed PPB (type III) with rhabdomyomatous and chondroid differentiation. After surgery, the patient was treated with regular chemotherapy and at follow-up was doing well without recurrence. In conclusion, PPB represents a rare pathological diagnosis. The present report highlights the significance of noting clinical symptoms in infants, promptly performing pulmonary imaging and pathological examinations, and performing genetic testing when required. Furthermore, long-term surveillance of families with DICER1 syndrome is vital for infants diagnosed with PPB.

Indexed as

diagnosisimaginginfantpleuropulmonary blastomatreatment

Identifiers

PMID39807108
PMCPMC11726280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.